The dynamic obstruction of the bladder outlet secondary to benign prostatic
hyperplasia (BPH), and the contractile properties of the human prostate ar
e mediated primarily by alpha(1)-adrenoceptors. There are now at least thre
e subtypes (A, B, and D) of alpha(1)-adrenoceptors, and recent work reveale
d that alpha(1A)-adrenoceptor and alpha(1B)-adrenoceptor may have a prime r
ole for prostatic obstruction, and contraction of artery, respectively. Ver
y recently, the presence of a low affinity alpha(1)-adrenoceptor for prazos
in, named alpha(1L), in the human BPH tissue has been determined. Because t
he DNA sequence of alpha(1L)-adrenoceptor has not yet been cloned, the alph
a(1L)-adrenoceptor may be another form of the alpha(1A)-adrenoceptor, or an
other pharmacologically distinct alpha(1)-adrenoceptor which mediates the n
orepinephrine-induced contraction of the prostatic smooth muscle. Furthermo
re, the contribution of alpha(1)-adrenoceptors in the prostate to symptoms
(not only obstructive, but irritative symptoms) which are elicited by prost
atic obstruction remains to be determined.